The Effect of Oral and Nasal Feeding on Cerebral Small Vessel Disease
NCT06248892 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88
Last updated 2024-03-12
Summary
Nasogastric tube feeding (NGT) has been widely used in cerebral small vessel disease (CSVD) patients with dysphagia but has a significant risk of complications. Intermittent Oro-esophageal Tube Feeding (IOE) is an established enteral nutrition approach that can be used with comprehensive rehabilitation therapy. This study aims to explore the clinical effect of IOE vs. NGT on CSVD Patients with Dysphagia. Compared to NGT, IOE, as an enteral nutrition support mode, in CSVD Patients with Dysphagia who received comprehensive rehabilitation therapy, showed advantages in improvement in dysphagia, nutritional status, ADL, QOL, pneumonia, and adverse events, which should be considered as the preferred approach.
Conditions
- Cerebral Small Vessel Diseases
Interventions
- DEVICE
-
Nasogastric Tube Feeding
Nasogastric Tube Feeding were used for feeding to provide nutritional support. Each feeding was administered by a nurse using the infant's mother's breast milk through the tube. The amount of each feeding varied from 20 to 100 ml depending on the age of the infant, with feedings given every 2 to 3 hours, approximately 10 times per day. The duration of each feeding procedure ranged from 10 to 20 minutes. The total daily intake ranged from 200 to 1000 ml. Each tube was kept indwelling for 5 to 7 days. When the tube needed to be replaced, it was removed after the last feeding of a day and a new tube was to be inserted through the other nostril on the following morning to continue the nutritional support.
- DEVICE
-
Intermittent Oro-esophageal Tube Feeding
The specific procedure was as follows: the infant was placed in a semi-recumbent or sitting position with the head fixed. Before each feeding, the infant's oral and nasal secretions were to be cleared. An intermittent oro-esophageal tube was appropriately lubricated with water on the head part. The professional medical staff held the tube and slowly inserted it through one side of the mouth into the upper part of the esophagus. The depth of insertion depended on the patient's age and height. After each feeding, the tube was immediately removed, and the patient was held upright for at least 30 minutes in case of reflux.
- BEHAVIORAL
-
comprehensive rehabilitation therapy
Both groups were given comprehensive rehabilitation therapy. The main intervention measures included: 1) non-invasive ventilator treatment, generally at least once every night and typically not exceeding continuous daily usage.; 2) attention to feeding and sleeping positions, with a recommended sleeping position of lateral recumbent and the head of the bed raised by 20-30°; 3) swallowing function training, such as tongue muscle stretching training, assisted anterior jaw protrusion training, lemon ice stimulation to the soft palate, pharyngeal wall, etc., generally 5 days per week, twice per day, 5-20 minutes each time; 4) pulmonary ultrashort wave therapy, generally at least 2-3 times a week, and not more than once a day; 5) physical therapy, such as intensive training for gross motor functions including lifting the head, turning over, sitting, crawling, standing, etc., generally 3-5 days per week, 1-2 times per day, 5-20 min each time.
Sponsors & Collaborators
-
Zeng Changhao
lead OTHER
Principal Investigators
-
Nieto Luis, Master · Site Coordinator of United Medical Group located in Miami
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-15
- Primary Completion
- 2024-04-30
- Completion
- 2024-05-31
Countries
- Thailand
Study Locations
More Related Trials
-
Phagenyx® Registry Study
NCT06866418 ·Status: RECRUITING
-
Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis
NCT06351735 ·Status: NOT_YET_RECRUITING
-
Tongue-strengthening Exercises in People With ALS.
NCT07295990 ·Status: RECRUITING ·Phase: NA
-
High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis
NCT00983983 ·Status: COMPLETED ·Phase: PHASE2
-
The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis
NCT01494480 ·Status: UNKNOWN ·Phase: PHASE2
-
Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness
NCT00937001 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)
NCT01016522 ·Status: TERMINATED ·Phase: PHASE3
-
Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis
NCT06391645 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis
NCT01609283 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Effects Strengthening Exercises in Individuals With ALS
NCT00204464 ·Status: COMPLETED ·Phase: PHASE2
-
Profile of Dysphagia in Myotonic Dystrophy Type 1 (DM1)
NCT05865483 ·Status: COMPLETED
-
Cortico-Spinal tDCS as Rehabilitative Intervention in Amyotrophic Lateral Sclerosis
NCT04293484 ·Status: COMPLETED ·Phase: NA
-
Use of the Passy Muir Swallowing Self Trainer
NCT02848664 ·Status: COMPLETED
-
Dynamic Impact of NIV on Diaphragmatic Ultrasound in Patients With Amyotrophic Lateral Sclerosis
NCT07170865 ·Status: NOT_YET_RECRUITING
-
Contribution of Diaphragmatic Ultrasound for Monitoring Diaphragmatic Function in Patients With Amyotrophic Lateral Sclerosis
NCT05352958 ·Status: RECRUITING
-
Tongue Strength in Amyotrophic Lateral Sclerosis (ALS)
NCT02665663 ·Status: UNKNOWN ·Phase: NA
-
External Pharyngeal Exerciser and Dysphagia
NCT05708898 ·Status: RECRUITING ·Phase: NA
-
Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management
NCT03738566 ·Status: COMPLETED ·Phase: NA
-
Quantitative Measurement of Nutritional Substrate Utilization in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00714220 ·Status: TERMINATED
-
Fatigue in Patients With Amyotrophic Lateral Sclerosis
NCT04468191 ·Status: WITHDRAWN ·Phase: NA
-
Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis
NCT06608004 ·Status: RECRUITING
-
Screening in Oculopharyngeal Muscular Dystrophy
NCT02877784 ·Status: COMPLETED
-
Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis
NCT07257302 ·Status: RECRUITING ·Phase: NA
-
Stem Cell Therapy for Amyotrophic Lateral Sclerosis
NCT01984814 ·Status: WITHDRAWN ·Phase: PHASE2
-
Treatment of Dysphagia Using the Mendelsohn Maneuver
NCT00592761 ·Status: COMPLETED ·Phase: PHASE1/PHASE2